Poehling Capital Management INC. Lowers Stake in CVS Health Corporation $CVS

Poehling Capital Management INC. decreased its holdings in shares of CVS Health Corporation (NYSE:CVS) by 42.7% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 22,048 shares of the pharmacy operator’s stock after selling 16,453 shares during the period. Poehling Capital Management INC.’s holdings in CVS Health were worth $1,521,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Slagle Financial LLC increased its position in CVS Health by 5.7% during the 2nd quarter. Slagle Financial LLC now owns 20,673 shares of the pharmacy operator’s stock valued at $1,426,000 after buying an additional 1,114 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH increased its holdings in shares of CVS Health by 14.4% during the second quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 810,150 shares of the pharmacy operator’s stock valued at $55,884,000 after acquiring an additional 101,671 shares in the last quarter. Generali Investments Management Co LLC boosted its stake in CVS Health by 117.9% in the 2nd quarter. Generali Investments Management Co LLC now owns 10,854 shares of the pharmacy operator’s stock worth $748,000 after purchasing an additional 5,873 shares in the last quarter. Bell Investment Advisors Inc grew its position in CVS Health by 55.6% during the 2nd quarter. Bell Investment Advisors Inc now owns 708 shares of the pharmacy operator’s stock valued at $49,000 after purchasing an additional 253 shares during the last quarter. Finally, Beta Wealth Group Inc. increased its stake in CVS Health by 1.3% during the 2nd quarter. Beta Wealth Group Inc. now owns 38,315 shares of the pharmacy operator’s stock valued at $2,643,000 after purchasing an additional 487 shares in the last quarter. 80.66% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the company. Wolfe Research boosted their price target on CVS Health from $80.00 to $85.00 and gave the stock an “outperform” rating in a research note on Monday, September 22nd. Cowen reissued a “buy” rating on shares of CVS Health in a research report on Monday, August 4th. Raymond James Financial lifted their price target on shares of CVS Health from $75.00 to $90.00 in a research note on Friday, October 31st. Cantor Fitzgerald increased their price objective on shares of CVS Health from $78.00 to $95.00 and gave the company an “overweight” rating in a research report on Thursday, October 30th. Finally, Truist Financial reaffirmed a “buy” rating and issued a $95.00 target price (up previously from $92.00) on shares of CVS Health in a research report on Thursday, October 30th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty-one have issued a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $89.41.

Insider Activity

In related news, Director Anne A. Finucane sold 7,500 shares of the stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total value of $532,650.00. Following the completion of the sale, the director directly owned 22,156 shares of the company’s stock, valued at approximately $1,573,519.12. This represents a 25.29% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 1.22% of the company’s stock.

CVS Health Stock Down 1.7%

Shares of CVS stock opened at $77.86 on Monday. The company has a 50 day simple moving average of $77.70 and a two-hundred day simple moving average of $69.96. The stock has a market cap of $98.84 billion, a P/E ratio of 204.90, a P/E/G ratio of 0.87 and a beta of 0.60. CVS Health Corporation has a 12 month low of $43.56 and a 12 month high of $85.15. The company has a current ratio of 0.83, a quick ratio of 0.62 and a debt-to-equity ratio of 0.83.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The firm had revenue of $102.87 billion during the quarter, compared to the consensus estimate of $98.85 billion. During the same quarter in the previous year, the firm posted $1.09 EPS. The company’s revenue for the quarter was up 7.8% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. On average, research analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd were given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.4%. The ex-dividend date of this dividend was Thursday, October 23rd. CVS Health’s payout ratio is presently 700.00%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.